308
Participants
Start Date
August 31, 2007
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
collagenase clostridium histolyticum
Subjects could have received up to three injections of AA4500 into the cord of the affected hand. Each injection was separated by at least 30 days. Individual cords may have received up to a maximum of three injections.
Placebo
Subjects could have received up to three injections of placebo into the cord of the affected hand. Each injection was separated by at least 30 days. Individual cords may have received up to a maximum of three injections.
Hospital for Special Surgery, New York
SUNY Stony Brook - Department of Orthopedics, Stony Brook
Hand Microsurgery & Reconstructive Orthopaedics, Erie
University Orthopedics Center, State College
The Hand and Upper Extremity Center of Georgia, P.C., Atlanta
The Indiana Hand Center, Indianapolis
TRIA Orthopaedic Center, Minneapolis
Rockford Orthopedic Associates, Ltd., Rockford
Health Research Institute, Oklahoma City
Hand Surgery Associates, PC, Denver
100 UCLA Medical Plaza, Suite 305, Los Angeles
Hand Surgery Clinic, Palo Alto
Brigham and Women's Hospital, Department of Orthopedic Surgery, Boston
Newton-Wellesley Hospital, Newton
Department of Orthopaedics, Brown University, Rhode Island Hospital, Providence
Lead Sponsor
Endo Pharmaceuticals
INDUSTRY